HT
SGMO

HAP Trading’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

HAP Trading’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-23,358
Closed -$248K – 1321
2019
Q1 		$223K Buy
23,358
+791
+4% +$8.08K 0.02% 426
2018
Q4 		$259K Buy
+22,567
New +$280K 0.02% 504

Other funds holding SGMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HAP Trading's SGMO Position: Q2 2019 in Review

HAP Trading sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2019, closing a stake of 23,358 shares — an estimated $248K sold.

HAP Trading first reported a position in SGMO in Q4 2018 and held it in 2 quarters. The position peaked at $259K in Q4 2018. 185 funds tracked by Wall St. Rank hold SGMO as of Q2 2019.

  • HAP Trading reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2019 after selling out during the quarter.
  • HAP Trading sold 23,358 SANGAMO THERAPEUTICS INC shares in Q2 2019, an estimated $248K.
  • HAP Trading first reported a position in SANGAMO THERAPEUTICS INC in Q4 2018 and held it in 2 quarters.
  • HAP Trading's SANGAMO THERAPEUTICS INC position peaked at $259K in Q4 2018.
  • 185 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2019.

Based on HAP Trading's 13F filing for Q2 2019, filed 14 Aug 2019.